Veytics Intelligence
2026-09-17 · NASDAQ

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

Key Points Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portfolio is performing well. Pfizer's cash stockpile further strengthens its ability to fund dividends. 10 stocks we like better than Pfizer › Pfizer 's (NYSE: PFE) forward dividend yield currently tops 6.2%. You can count the number of S&P 500 (SNPINDEX: ^GSPC) members with higher yields on your fingers -- and have several fingers to spare. Does Pfizer's dividend program face big questions? Absolutely. However, that doesn't mean the drugmaker's dividend is in imminent jeopardy. Here are three reasons Pfizer's dividend should survive. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。